• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INSET¿; INSET I 60/9 GREY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INSET¿; INSET I 60/9 GREY Back to Search Results
Lot Number 5147521
Medical Device Problem Code Detachment of Device or Device Component (2907)
Health Effect - Clinical Code Elevated ketones/Diabetic Ketoacidosis (2364)
Type of Reportable Event Malfunction
Event or Problem Description
(b)(4).Event occurred in the united states.The patient reported that the infusion set tubing broke approximately 4 inches from the luer-lock connection.The patient also stated that the tubing appeared to have been cut.The patient had high blood glucose level reported to be over 240 mg/dl, which was treated with a manual injection of insulin.The patient also had high level of ketones.The patient did not notice any damage when the package was first opened.The patient was able to successfully apply a new infusion set to the customer and resume insulin on the pump.No further information available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INSET¿
Common Device Name
INSET I 60/9 GREY
MDR Report Key8463046
Report Number3003442380-2019-00729
Device Sequence Number16479139
Product Code FPA
UDI-Device Identifier05705244006881
UDI-Public05705244006881
Combination Product (Y/N)N
PMA/510(K) Number
K032854
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source distributor
Initial Reporter Occupation Other
Type of Report Initial
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device No Information
Device Lot Number5147521
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/24/2017
Initial Report FDA Received Date03/29/2019
Patient Sequence Number1
-
-